D
BioNTech SE BNTX
$96.39 -$0.34-0.35% NASDAQ
Recommendation
Prev Close
$96.73
Volume
419,356
Avg Vol (90D)
944,375
Market Cap
$23.26B
Dividend & Yield
--
52-Week Range
$81.20 - $129.27
P/E (TTM)
--
EPS (TTM)
-$2.63
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
BioNTech Achieves Minimum Condition in CureVac Exchange Offer
12/3/2025 - Globe Newswire
Study Finds Tattoo Ink Moves Through the Body, Killing Immune Cells
12/3/2025 - Slashdot
BioNTech SE American Depositary Share (BNTX, $97.39) price exceeded its 50-day Moving Average on December 01, 2025
12/2/2025 - Tickeron - Stocks
Vaccine Stocks Fall After FDA Plans to Impose Stricter Vaccine Rules
12/2/2025 - Zacks Investment Research
Groupama Asset Managment Buys 26,681 Shares of BioNTech SE Sponsored ADR $BNTX
11/29/2025 - MarketBeat
BioNTech SE American Depositary Share (BNTX, $103.15) price moved above its 50-day Moving Average on November 28, 2025
11/29/2025 - Tickeron - Stocks
Tattoo ink moves through body, killing immune cells, study says
11/28/2025 - Orange County Register: Business
Legal & General Group Plc Boosts Stock Position in BioNTech SE Sponsored ADR $BNTX
11/28/2025 - MarketBeat
Edmond DE Rothschild Holding S.A. Raises Stock Position in BioNTech SE Sponsored ADR $BNTX
11/27/2025 - MarketBeat
BioNTech Advances with CureVac Exchange Offer Approval
11/26/2025 - TipRanks Financial Blog
Berenberg Bank Reaffirms Buy Rating for BioNTech (NASDAQ:BNTX)
11/26/2025 - MarketBeat
BioNTech Shares Progress on Exchange Offer for CureVac Shares and Highlights December 3, 2025, at 9:00 a.m. Eastern Time Expiration
11/26/2025 - Globe Newswire
Franklin Resources Inc. Acquires 326,556 Shares of BioNTech SE Sponsored ADR $BNTX
11/26/2025 - MarketBeat
BioNTech SE American Depositary Share (BNTX, $96.54) RSI Indicator left the oversold zone on November 24, 2025
11/25/2025 - Tickeron - Stocks
BioNTech SE Sponsored ADR $BNTX Shares Purchased by CenterBook Partners LP
11/23/2025 - MarketBeat
BioNTech SE American Depositary Share (BNTX, $95.59) RSI Indicator left the oversold zone on November 21, 2025
11/22/2025 - Tickeron - Stocks
Bank Julius Baer & Co. Ltd Zurich Lowers Stock Holdings in BioNTech SE Sponsored ADR $BNTX
11/22/2025 - MarketBeat
BioNTech SE American Depositary Share (BNTX, $96.97) price may climb as it broke lower Bollinger Band on Nov 20, 2025
11/21/2025 - Tickeron - Stocks
BioNTech SE American Depositary Share (BNTX, $102.67) price exceeded its 50-day Moving Average on November 17, 2025
11/18/2025 - Tickeron - Stocks
BioNTech SE (BNTX) Discusses Oncology Innovation Strategy, Combination Therapies and Personalized Cancer Immunotherapies Transcript
11/17/2025 - Seeking Alpha: Transcripts
BioNTech SE (BNTX) Discusses Oncology Innovation Strategy, Combination Therapies and Personalized Cancer Immunotherapies Transcript
11/17/2025 - SeekingAlpha
BMY Stock Down on Discontinuation of ACS Clinical Study With JNJ
11/17/2025 - Zacks Investment Research
Mitsubishi UFJ Trust & Banking Corp Sells 17,597 Shares of BioNTech SE Sponsored ADR $BNTX
11/16/2025 - MarketBeat
Fox Run Management L.L.C. Purchases New Holdings in BioNTech SE Sponsored ADR $BNTX
11/15/2025 - MarketBeat
Allianz SE Buys 5,080 Shares of BioNTech SE Sponsored ADR $BNTX
11/15/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
$3.53B
EBITDA (TTM)
-$509.70M
EBIT (TTM)
-$885.53M
Net Income (TTM)
-$633.26M
Balance Sheet
Total Assets (Q)
$25.04B
Total Debt (Q)
$287.93M
Total Liabilities (Q)
$3.36B
Book Value Per Share (Q)
$90.16
Cash Flow
Cash from Operations (TTM)
-$236.43M
Cash from Investing (TTM)
$803.92M
Cash from Financing (TTM)
-$50.84M
Net Change in Cash (TTM)
$481.05M
Filings
Filing Date
Monday, November 3, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Mar 9 and 13 (est)
Price History
Loading...
Beta
0.56
7-Day Total Return
-0.16%
30-Day Total Return
-9.26%
60-Day Total Return
-4.56%
90-Day Total Return
-13.54%
Year to Date Total Return
-16.40%
1-Year Total Return
-15.96%
2-Year Total Return
-3.52%
3-Year Total Return
-42.18%
5-Year Total Return
-18.90%
52-week Low
Apr 07, 2025 - $81.20
52-week High
Jan 07, 2025 - $129.27
Valuation
Market Cap
$23.26B - Large Cap
Enterprise Value
$6.50B
Price/Sales (TTM)
6.55
Price/Book (Q)
1.07
Dividends and Shares
Shares Outstanding
239.17
Dividend Per Share (Most Recent)
$1.55
Dividend Per Share (TTM)
--
Corporate Info
Website
www.biontech.de
Phone Number
49 6131 9084
Address
An der Goldgrube 12
Mainz, 55131
Country
Germany
Year Founded
2008
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany. The company develops BNT111, which is in Phase 2 clinical... more
NASDAQ 12/04/2025 10:27AM Eastern Quotes delayed